Drugs & Therapy Perspectives

, Volume 7, Issue 7, pp 13–13 | Cite as

Addendum: Combined OCs and thromboembolism — risk data now published



  1. 1.
    Combined oral contraceptives and thromboembolism [letter]. London: Committee on Safety of Medicines, 1995 Oct 18Google Scholar
  2. 2.
    World Health Organization. Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. Lancet 1995 Dec 16; 346: 1582–8Google Scholar
  3. 3.
    Jick H, Jick SS, Gurewich V, et al. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet 1995 Dec 16; 346: 1589–92PubMedCrossRefGoogle Scholar
  4. 4.
    Spitzer WO, Lewis MA, Heinemann LAJ, et al. Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Br Med J 1996 Jan 13; 312: 83–7CrossRefGoogle Scholar
  5. 5.
    British National Formulary No. 30. London: The Pharmaceutical Press, 1995 Sep; 328Google Scholar

Copyright information

© Adis lnternational Limited 1996

Personalised recommendations